Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.
One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...
In response to global scrutiny, the Indian government will likely announce plans to set up new drug testing labs and increase ...